anticipated

SMC Announces Marketing Agreement with Plato Technologies. Inc.

  BOCA RATON, FL / Plato / Amplifi / April 18,2024 / SMC Entertainment, Inc. ("SMC" or the "Company") (OTC PINK: SMCE) SMC / (PINK:SMCE) is pleased to announce a marketing agreement and collaboration with Plato Technologies Inc. Plato Technologies specializes in AI content disruption and AI management systems. The collaboration will enable the Company to market Plato's platform directly to web and content development teams. The companies have agreed on a revenue sharing agreement after deducting individual client acquisition costs. "This is just the beginning." stated Erik Blum CEO

TCG World Announces Partnership with Chooky Records to Revolutionize Entertainment in the Metaverse

Los Angeles, CA - March 8th, 2024. In an innovative fusion of music and virtual experiences, TCG World, a trailblazer in the development of immersive metaverse environments, has joined forces with the dynamic music label, Chooky Records. This collaboration is set to enrich the metaverse with unparalleled musical and visual entertainment, starting with the exclusive metaverse premiere of the music video "Chooky" featuring Elesia Iimura, O.T., and the legendary Busta Rhymes. TCG World is carving a unique path in the gaming industry by creating a one-of-a-kind metaverse that goes beyond

HDEX Releases “Hydrogen Horizons 2024-2050” Market Report

HDEX, the world’s first hydrogen exchange, is thrilled to announce complimentary access to its highly anticipated report, titled “Hydrogen Horizons 2024-2050: Navigating the Global Hydrogen Market.” LONDON CITY, UK; FEBRUARY 29, 2024 – HDEX, the world’s first hydrogen exchange, is thrilled to announce complimentary access to its highly anticipated report, titled “Hydrogen Horizons 2024-2050: Navigating the Global Hydrogen Market.” This comprehensive 66-page report offers invaluable insights into the future of the hydrogen market, encompassing market trends, growth opportunities, and strategic recommendations. “The global hydrogen market stands on the cusp of

Skyward Bound: HDEX brings eFrancisco Motors and LuftCar Together For Groundbreaking Partnership

A New Electric Vertical Take-off and Landing (eVTOL) Project Begins FOR IMMEDIATE RELEASE Camarines Norte, Philippines – January 28, 2024 HDEX is proud to announce that two partners, eFrancisco Motor Corporation and Luftcar have come together to develop a new Electric Vertical Take-off and Landing (eVTOL) project. The focal point of this groundbreaking collaboration is the development of the LUFT PINOY eVTOL powered by Hydrogen. Aron Dutta, Chairman of HDEX, stated, “HDEX was pleased to help facilitate this exciting partnership. What is happening in the Philippines will be the case

PPS From Durham Unveils Highly Anticipated Album “Eriaz~” and Set to Perform Live at Coast2Coast in Atlanta

Durham, NC - January 27, 2024 - Renowned hip-hop artist PPS From Durham is set to take the stage at Coast2Coast in Atlanta on January 28th, 2024, to celebrate the release of his much-anticipated album, "Eriaz~." Fans and music enthusiasts alike are eagerly awaiting this momentous occasion, as PPS From Durham gears up to deliver an electrifying performance showcasing tracks from his latest project. With "Eriaz~," PPS From Durham continues to captivate audiences with his unique blend of lyricism, storytelling, and innovative soundscapes. The album serves as a testament to

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

American Picture House Corporate Update

New York, NY, Raleigh, NC, and Los Angeles, CA.  September 6, 2023 – American Picture House Corporation (OTC: APHP), an entertainment company with a focus on producing feature films, limited series, and entertainment enhancing technologies, today provided a corporate update for shareholders. Industry Strikes American Picture House supports the ideals behind the two current industry strikes -- brought by the Writers Guild of America (“WGA”) and the Screen Actors Guild (“SAG”) -- and joins the many reasonable voices urging for a fair and timely resolution. Update on Feature Films -

Starbox Group’s StarboxAI – ViPro Module: Transforming Content Creation

Kuala Lumpur, Malaysia, Sept 5th, 2023 – Starbox Group Holdings Ltd. (Nasdaq: STBX), a dynamic player in cash rebates, digital advertising, and payment solutions, with a vision of leading in artificial intelligence (“AI”) solutions throughout Southeast Asia, is making waves with the launch of its groundbreaking StarboxAI - ViPro module. This innovative module introduces a text-to-video feature set to redefine content creation. The Text-to-Video feature within the StarboxAI - ViPro module is not just an addition; it's a revelation. It empowers content creators to seamlessly transmute textual instructions or scripts

Starbox Group Holdings Ltd. Announces First Half of Fiscal Year 2023 Financial Results

Revenue and Net Profit Increased with Technology Driven Services Revenue Accounted for Approximately 43.8% of its Revenue KUALA LUMPUR, Malaysia, August 29, 2023 / Plato / Amplifi. Starbox Group Holdings Ltd. (Nasdaq: STBX) ("Starbox" or "the Company”), a service provider of cash rebates, digital advertising, and payment solutions with a goal of becoming a comprehensive AI solutions provider within Southeast Asia, today announced its unaudited financial results for the six months ended March 31, 2023. Mr. Lee Choon Wooi, Chairman and Chief Executive Officer of Starbox, commented, “We are excited

Livento Group, Inc. Announces Second Quarter Results with Revenue Growth of Over 90%, Including Significant Achievements and Updates

NEW YORK, NY / August 14, 2023 / NuGene International, Inc./Livento Group, Inc. (OTC Pink:NUGN), a dynamic leader specializing in the acquisition and development of companies with disruptive business models in film, content, and technology sectors, is pleased to announce revenue growth of 91.65% for the second quarter of 2023, compared to the same period in 2022. Financial Highlights: Revenue Growth:The second quarter ending June 30, 2023, saw revenues of $431,184, up from $224,986 in 2022. For the six-month period ending June 30, 2023, revenues grew from $680,202 to $922,651, a growth of

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating